Targeting Pathways Downstream Of KRAS In Lung adenocarcinoma
Pharmacogenomics (2014) 15(11), 1507–1518 ISSN 1462-2416. 1507. part of. Review. Targeting pathways downstream of KRAS in lung adenocarcinoma . Review. ways will have emerged, incorporating novel therapeu-tic approaches such as the inhibition of RAL-GEF and ... Return Document
Clinical-Pathological Correlation Of KRAS Mutation Status In ...
Clinical-Pathological Correlation of KRAS Mutation Status in Metastatic Colorectal Adenocarcinoma Karen Bento Ribeiroa, Karoline Bento Ribeirob, rectal adenocarcinoma, and 83.1% of patients did not exhibit obstructive and/or perforated acute abdomen at the time of ... Fetch Full Source
Oncogenic RIT1 Mutations In Lung adenocarcinoma
Oncogenic RIT1 mutations in lung adenocarcinoma (Article begins on next page) The Harvard community has made this article openly available. RTK/RAS pathway members KRAS, EGFR, BRAF and ERBB2, and translocations involving ALK, RET and ROS1. ... Return Doc
Review Article - The New England Journal Of Medicine
Pancreatic Adenocarcinoma n engl j med 371;11 nejm.org 11september , 2014 1043 thesis and protein glycosylation. In addition, KRAS promotes the use of glutamine for both ... Access Full Source
KrasG12D And Nkx2-1 Haploinsufficiency Induce Mucinous ...
Mutant Kras–driven mucinous adenocarcinoma. Results Haploinsufficiency of Nkx2-1 induced mucinous adenocarcinomas dur-ing KrasG12D tumorigenesis. In order to determine whether reduced expression of Nkx2-1 influences the pathogenesis of invasive ... Document Retrieval
Subtype-specific KRAS Mutations In Advanced Lung ...
Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy Mihaly Cserepesa,b,c,1, Gyula Ostorosb,1, Zoltan Lohinaia,c, Erzsebet Rasod,e, ... Access Document
BRAF (gene) - Wikipedia, The Free Encyclopedia
BRAF is a human gene that makes a protein called B-Raf. The gene is also referred to as proto-oncogene B-Raf and v-Raf murine sarcoma viral oncogene homolog B, non-small-cell lung carcinoma, and adenocarcinoma of the lung. [6] ... Read Article
Mutant KRAS Is A Druggable Target For Pancreatic Cancer
Mutant KRAS is a druggable target for pancreatic cancer Elina Zorde Khvalevskya, Pancreatic ductal adenocarcinoma (PDA) representsan unmet ther- This article is a PNAS Direct Submission. 1To whom correspondence should be addressed. ... View Document
Lipophilic Bisphosphonates Plus Rapamycin: A Deadly ...
Lipophilic bisphosphonates plus rapamycin: a deadly combination for KRAS-mutated lung adenocarcinoma Wei Liu1,2, Ting Zhang 1, Lixia Guo , Yanan Yang1,3,4 1Thoracic Disease Research Unit, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA; 2Department ... Access Document
KRAS Mutations In Ovarian Low-grade Endometrioid ...
Original contribution KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis Colin J.R. Stewart FRCPAa,⁎, Yee Leung FRANZCOGb, Michael D. Walsh PhDc, ... Fetch This Document
A Teenager With Lung Mucinous adenocarcinoma Harboring A KRAS ...
A teenager with lung mucinous adenocarcinoma harboring a KRAS mutation arising in type 1 congenital cystic adenomatoid malformation (CCAM) Pedro Masson Dominguesa,n, Tatiane Montellaa, Clarissa Baldottoa, ... Doc Retrieval
Papillary Thyroid Cancer - Wikipedia, The Free Encyclopedia
Papillary thyroid cancer or papillary thyroid carcinoma [1] is the most common type of thyroid cancer, [2] representing 75 percent to 85 percent of all thyroid cancer cases. [1] ... Read Article
Impact Of EGFR Mutations And KRAS - WOMEN IN MEDICINE LTD
Impact of EGFR mutations and KRAS amino acid substitution on the response to radiotherapy for brain metastasis of non-small-cell lung cancer In France, m EGFR are more frequent with adenocarcinoma (ADC) in females and never smokers. ... Retrieve Here
Identifi K-Ras Driven Lung adenocarcinoma
Cho HC, Lai CY, Shao LE, Yu J (2011) Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma. Cancer Res 71(23):7250–7258. 7. Guerra C, et al. (2003) Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. ... Get Document
EGFR And KRAS Mutations In Lung Carcinoma: Molecular Testing ...
EGFR and KRAS Mutations in Lung Carcinoma: Molecular Testing Using Cytology Specimens Shahreen Billah, molecular testing using cytology specimens for Calculated to compare the mutations between adenocarcinoma and non-adenocarcinoma . ... Fetch Document
Ethnicity Affects EGFR And KRAS Gene Alterations Of Lung ...
1778 SOH et al: ETHNICITY AND EGFR/KRAS PROFILES OF LUNG ADENOCARCINOMA Ethnic differences of EGFR and KRAS alterations with respect to gender and smoking status. ... Read Here
Differences In EGFR And KRAS Mutation Spectra In Lung ...
1210 TAKAMOCHI et al: EGFR AND KRAS MUTATION SPECTRA IN LUNG ADENOCARCINOMA Discussion Tobacco smoking is the main cause of lung cancer world-wide. ... Read Full Source
Karyopharm’s Selinexor First-in-Human Phase 1 Clinical Trial Data Published In Journal Of Clinical Oncology
NEWTON, Mass., March 04, 2016-- Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, announced today the publication of results from a Phase 1 clinical trial of selinexor in patients ... Read News
Cancer Cell Article - ResearchGate
Cancer Cell Article KrasG12D and Smad4/Dpc4 Haploinsufficiency Cooperate to Induce Mucinous Cystic Neoplasms and Invasive Adenocarcinoma of the Pancreas ... Retrieve Doc
Alan P. Venook, Et Al. - YouTube
Alan P. Venook, et al. oncoletter. Subscribe Subscribed Unsubscribe 334 334. Loading (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum ... View Video
KRAS Testing Before Anti-EGFR Therapy - About.com Health
KRAS testing, which is a test to see which version of the KRAS gene your colon cancer tumor has, is an important first step to determining if your treatment should include anti-EGFR therapy. ... Read Article
Author’s Accepted Manuscript
Author’s Accepted Manuscript Radiation-induced KRAS G12V mutant lung adenocarcinoma in a never smoker Maeghan P. Gibson, Joseph Sailors, Dwight H. ... Doc Viewer
No comments:
Post a Comment